Skip to main content
. 2022 Oct 12;22:266. doi: 10.1186/s12906-022-03742-7

Table 1.

Antimalarial activity against P. falciparum and the cytotoxicity of compounds from M. siamensis

Compound IC50 (µM) CC50 (µM)
K1 Vero cell HepG2
Lupeol (1) 18.78 ± 3.45a,b > 80 29.27 ± 1.47a,b
4,5-Dihydroxy-3-methoxylxanthone (2) 20.96 ± 3.56a,b > 80 > 80
4-Hydroxyxanthone (3) 68.55 ± 2.54a,b 48.13 ± 1.68 a,b 46.12 ± 1.66 a,b
1,7-Dihydroxyxanthone (4) 41.67 ± 2.23a,b 7.90 ± 0.90 13.27 ± 1.12 a,b
Mixture of β-sitosterol and stigmasterol (5) 45.00 ± 3.51a,b > 80 > 80
Mammea A/AA cyclo D (6) 45.62 ± 3.12a,b > 80 > 80
Mammea A/AA cyclo F (7) 49.89 ± 0.42a,b > 80 > 80
1,6-Dihydroxyxanthone (8) 47.94 ± 5.16a,b > 80 > 80
1-Hydroxy-5,6,7-trimethoxyxanthone (9) 9.57 ± 1.59 a,b > 80 > 80
3,4,5-Trihydroxyxanthone (10) 15.48 ± 2.63a,b > 80 > 80
5-Hydroxy-1-methoxyxanthone (11) 29.32 ± 4.44a,b > 80 > 80
2-Hydroxyxanthone (12) 74.97 ± 0.88 a,b > 80 > 80
1,5-Dihydroxy-6-methoxyxanthone (13) 22.27 ± 1.67a,b > 80 30.54 ± 1.49 a,b
Chloroquine* 103.2 ± 4.50 ND ND
Artesunate* 0.53 ± 0.04 ND ND
Doxorubicin ND 1.46 ± 0.16 1.11 ± 0.05

ND = not determined

aStatistically significant difference between chloroquine and the compound, p < 0.05 (mean ± S.D. of three determinations)

bStatistically significant difference between artesunate and the compound, p < 0.05 (mean ± S.D. of three determinations)

*Concentration of positive control with IC50 unit expressed in nM